US Patent Issued to Theriva Biologics on July 28 for "Alkaline phosphatase formulations and uses thereof" (British, American Inventors)

ALEXANDRIA, Va., July 28 -- United States Patent no. 12,691,077, issued on July 28, was assigned to Theriva Biologics Inc. (Rockville, Md.).

"Alkaline phosphatase formulations and uses thereof" was invented by Michael Kaleko (Rockville, Md.), Ray Stapleton (Rockville, Md.), Andrew Bristol (Rockville, Md.), Steven Hubert (Rockville, Md.) and Cristina Freire (Oxford, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides, in part, formulations comprising an alkaline phosphatase. Particularly, modified-release formulations comprising an alkaline phosphatase are provided, which release a substantial amount of the alkaline phosphatase in the intestines. Therapeutic uses of the...